1. Home
  2. SYRE vs ARIS Comparison

SYRE vs ARIS Comparison

Compare SYRE & ARIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • ARIS
  • Stock Information
  • Founded
  • SYRE 2013
  • ARIS 2015
  • Country
  • SYRE United States
  • ARIS United States
  • Employees
  • SYRE N/A
  • ARIS N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • ARIS Water Supply
  • Sector
  • SYRE Health Care
  • ARIS Utilities
  • Exchange
  • SYRE Nasdaq
  • ARIS Nasdaq
  • Market Cap
  • SYRE 841.4M
  • ARIS 828.4M
  • IPO Year
  • SYRE 2016
  • ARIS 2021
  • Fundamental
  • Price
  • SYRE $14.10
  • ARIS $21.54
  • Analyst Decision
  • SYRE Buy
  • ARIS Buy
  • Analyst Count
  • SYRE 8
  • ARIS 6
  • Target Price
  • SYRE $50.00
  • ARIS $26.00
  • AVG Volume (30 Days)
  • SYRE 553.9K
  • ARIS 696.6K
  • Earning Date
  • SYRE 05-08-2025
  • ARIS 05-06-2025
  • Dividend Yield
  • SYRE N/A
  • ARIS 2.59%
  • EPS Growth
  • SYRE N/A
  • ARIS 16.74
  • EPS
  • SYRE N/A
  • ARIS 0.83
  • Revenue
  • SYRE N/A
  • ARIS $452,529,000.00
  • Revenue This Year
  • SYRE N/A
  • ARIS $12.52
  • Revenue Next Year
  • SYRE N/A
  • ARIS $7.90
  • P/E Ratio
  • SYRE N/A
  • ARIS $26.04
  • Revenue Growth
  • SYRE N/A
  • ARIS 12.03
  • 52 Week Low
  • SYRE $10.91
  • ARIS $13.34
  • 52 Week High
  • SYRE $40.49
  • ARIS $33.95
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 48.32
  • ARIS 37.10
  • Support Level
  • SYRE $12.29
  • ARIS $19.70
  • Resistance Level
  • SYRE $15.77
  • ARIS $26.75
  • Average True Range (ATR)
  • SYRE 1.06
  • ARIS 1.25
  • MACD
  • SYRE 0.08
  • ARIS -0.34
  • Stochastic Oscillator
  • SYRE 52.08
  • ARIS 26.10

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About ARIS Aris Water Solutions Inc.

Aris Water Solutions Inc is an environmental infrastructure and solutions company delivering full-cycle water handling and recycling solutions. Its integrated pipelines and related infrastructure create long-term value by delivering high-capacity, comprehensive produced water management, recycling, and supply solutions to operators in the core areas of the Permian Basin. The company manages its business through a single operating segment comprising two primary revenue streams, Produced Water Handling and Water Solutions. The Produced Water Handling business gathers, transports, and unless recycled, handles produced water generated from oil and natural gas production, and the Water Solutions business develops and operates recycling facilities to treat, store, and recycle produced water.

Share on Social Networks: